These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 16111302)

  • 21. Scleritis as the presenting manifestation of procainamide-induced lupus.
    Turgeon PW; Slamovits TL
    Ophthalmology; 1989 Jan; 96(1):68-71. PubMed ID: 2645552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiguanosine antibodies: a new marker for procainamide-induced systemic lupus erythematosus.
    Weisbart RH; Yee WS; Colburn KK; Whang SH; Heng MK; Boucek RJ
    Ann Intern Med; 1986 Mar; 104(3):310-3. PubMed ID: 3511820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antinuclear antibodies.
    Peltier AP; Estes D
    Pathobiol Annu; 1972; 2():77-109. PubMed ID: 4129769
    [No Abstract]   [Full Text] [Related]  

  • 24. The lupus erythematosus cell phenomenon: comparative analysis of antichromatin antibody specificity in lupus erythematosus cell-positive and -negative sera.
    Schett G; Rubin RL; Steiner G; Hiesberger H; Muller S; Smolen J
    Arthritis Rheum; 2000 Feb; 43(2):420-8. PubMed ID: 10693884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro production of antibodies to histones in patients receiving chronic procainamide therapy.
    Mongey AB; Hess E
    J Rheumatol; 2001 Sep; 28(9):1992-8. PubMed ID: 11550965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The diagnostic value of antihistone antibodies in drug-induced lupus erythematosus.
    Epstein A; Barland P
    Arthritis Rheum; 1985 Feb; 28(2):158-62. PubMed ID: 3882094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibodies to histones in systemic lupus erythematosus and drug-induced lupus syndromes.
    Monestier M; Kotzin BL
    Rheum Dis Clin North Am; 1992 May; 18(2):415-36. PubMed ID: 1626076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Anti ribosomal P antibody].
    Kawabata M; Tamai S
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():533-6. PubMed ID: 20942122
    [No Abstract]   [Full Text] [Related]  

  • 29. [Immunologic tests: Antinuclear antibody].
    Hayashi N; Kumagai S
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():456-9. PubMed ID: 16111300
    [No Abstract]   [Full Text] [Related]  

  • 30. Role of anti-nucleosome antibody in the diagnosis of systemic lupus erythematosus.
    Su Y; Jia RL; Han L; Li ZG
    Clin Immunol; 2007 Jan; 122(1):115-20. PubMed ID: 17085075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
    Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
    Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug-induced lupus erythematosus syndrome. Immuno-pathological, electronmicroscopical and serological studies.
    Ullman S; Wiik A; Kobayasi T; Halberg P
    Acta Derm Venereol; 1974; 54(5):387-90. PubMed ID: 4138086
    [No Abstract]   [Full Text] [Related]  

  • 33. Anti-C1q antibodies in juvenile-onset systemic lupus erythematosus.
    Jesus AA; Silva CA; Carneiro-Sampaio M; Sheinberg M; Mangueira CL; Marie SK; Liphaus BL
    Ann N Y Acad Sci; 2009 Sep; 1173():235-8. PubMed ID: 19758156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Anti-proliferating cell nuclear antigen (PCNA) antibody].
    Takasaki Y
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():578-81. PubMed ID: 20942134
    [No Abstract]   [Full Text] [Related]  

  • 35. Antibodies to histones of the IgG and IgM class in systemic lupus erythematosus.
    Krippner H; Springer B; Merle S; Pirlet K
    Clin Exp Immunol; 1984 Oct; 58(1):49-56. PubMed ID: 6332696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-histone antibodies in idiopathic and drug-induced lupus recognize distinct intrahistone regions.
    Portanova JP; Arndt RE; Tan EM; Kotzin BL
    J Immunol; 1987 Jan; 138(2):446-51. PubMed ID: 2432124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Skin immunofluorescence studies on lupus erythematosus and other antinuclear-antibody-positive diseases.
    Grossman J; Callerame ML; Condemi JJ
    Ann Intern Med; 1974 Apr; 80(4):496-500. PubMed ID: 4621260
    [No Abstract]   [Full Text] [Related]  

  • 38. Drug-induced anti-histone autoantibodies display two patterns of reactivity with substructures of chromatin.
    Burlingame RW; Rubin RL
    J Clin Invest; 1991 Aug; 88(2):680-90. PubMed ID: 1864977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serologic evaluation of patients receiving procainamide.
    Mongey AB; Donovan-Brand R; Thomas TJ; Adams LE; Hess EV
    Arthritis Rheum; 1992 Feb; 35(2):219-23. PubMed ID: 1734911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosing systemic lupus erythematosus: new-generation immunoassays for measurement of anti-dsDNA antibodies are an effective alternative to the Farr technique and the Crithidia luciliae immunofluorescence test.
    Antico A; Platzgummer S; Bassetti D; Bizzaro N; Tozzoli R; Villalta D;
    Lupus; 2010 Jul; 19(8):906-12. PubMed ID: 20179169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.